Top Markets
Coin of the day
Bio-Path Holdings, Inc. Bio-Path Holdings, Inc.

Bio-Path Holdings, Inc.

BPTH
Classifica tra le azioni #39844
Bio-Path Holdings, Inc. is a U.S.-based pharmaceutical company focused on... Bio-Path Holdings, Inc. is a U.S.-based pharmaceutical company focused on developing RNAi nanoparticle drugs for oncology, with programs spanning both clinical and preclinical stages. Its innovative product development is centered around the DNAbilize platform, a drug delivery and antisense technology that employs a P-ethoxy modified deoxyribonucleic acid (DNA) backbone. This modification is specifically engineered to shield the DNA from premature degradation. The company's lead drug candidate, prexigebersen, is presently in Phase II clinical trials for the treatment of acute myeloid leukemia (AML) and myelodysplastic syndrome. Additionally, Bio-Path is advancing Liposomal Bcl-2 for refractory/relapsed lymphoma and chronic lymphocytic leukemia. Another promising asset, Liposomal STAT3, is in preclinical development, targeting pancreatic cancer, non-small cell lung cancer, and AML. Furthermore, prexigebersen-A is under development for various solid tumors. Bio-Path Holdings, Inc., founded in 2007, is headquartered in Bellaire, Texas.
Prezzo delle azioni
$0.035
Ultima sincronizzazione: 2026-08-13
Capitalizzazione di mercato
$326.98K
Variazione (1 giorno)
-12.50%
Variazione (1 anno)
-74.55%
Paese
US
Scambia Bio-Path Holdings, Inc. (BPTH)

Categoria

Storico del prezzo dell'azione per Bio-Path Holdings, Inc. (BPTH)
Prezzo di chiusura più alto: $0.04 il 2026-08-01

Prezzo di chiusura più basso: $2.50K il 2006-02-01
Storico del prezzo dell'azione di Bio-Path Holdings, Inc. dal 2006 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2026 (TTM) -9.36%
2025 -91.80%
2024 -91.13%
2023 -66.41%
2022 -65.24%
2021 16.03%
2020 -52.69%
2019 59.95%
2018 -88.85%
2017 -82.76%
2016 -18.86%
2015 -40.35%
2014 -11.72%
2013 803.53%
2012 3.58%
2011 -14.96%
2010 -14.88%
2009 4.80%
2008 -52.90%
2007 18.00%
2006 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
$517.18 32.51%
US
$857.76 31.47%
NL
$744.96 9.07%
CH
$1.07K -6.40%
KR
$259.89 14.81%
BE